Bayerische Motoren Werke Aktiengesellschaft Stock Forecast, Price & News (ETR:BMW)

We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer’s, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.

May 16, 2023… The Day That Will Financially Paralyze 181 Million American Investors… Here are 3 steps to prepare yourself >>>

Bayerische Motoren Werke Aktiengesellschaft, together with its subsidiaries, engages in the development, manufacture, and sale of automobiles and motorcycles, and spare parts and accessories worldwide. It operates through Automotive, Motorcycles, and Financial Services segments. The Automotive segment engages in the development, manufacture, assembling, and sale of automobiles, spare parts, accessories, and mobility services under the BMW, MINI, and Rolls-Royce brands. The Motorcycles segment develops, manufactures, assembles, and sells motorcycles and scooters under the BMW Motorrad brand, as well as spare parts and accessories. The Financial Services segment is involved in the automobile and motorcycle leasing, credit financing, retail and dealership financing, multi-brand fleet, customer deposit, and insurance activities; and the provision of fleet management services under the Alphabet brand. The company sells its products through independent dealerships and importers. Bayerische Motoren Werke Aktiengesellschaft was founded in 1916 and is headquartered in Munich, Germany.

Receive BMW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bayerische Motoren Werke Aktiengesellschaft and its competitors with MarketBeat’s FREE daily newsletter.

Email Address

Industry, Sector and Symbol

Price Target and Rating

Average Stock Price Forecast

€101.60

High Stock Price Forecast

€120.00

Low Stock Price Forecast

€85.00

Forecasted Upside/Downside

-7.6%

Consensus Rating

Rating Score (0-4)

0.00

Research Coverage

0 Analysts

Profitability

Debt

Sales & Book Value

Miscellaneous

Outstanding Shares

602,000,000

Free Float

N/A

Market Cap

$66.17 billion

Optionable

Not Optionable

Beta

1.10